Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-15 Sale | 2023-05-18 2:38 pm | Aceragen Inc. | ACGN | Chopra Atul 10% Owner | 135,672 | $1.4406 | $195,447 | 1,205,158 (Indirect) | View |
| 2023-05-12 Sale | 2023-05-18 2:35 pm | Aceragen Inc. | ACGN | Chopra Atul 10% Owner | 81,486 | $1.5579 | $126,947 | 1,340,830 (Indirect) | View |
| 2023-05-11 Sale | 2023-05-18 2:34 pm | Aceragen Inc. | ACGN | Chopra Atul 10% Owner | 47,166 | $1.8429 | $86,924 | 1,422,316 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2023-03-28 11:16 am | N/A N/A | Aceragen Inc. | ACGN | Chopra Atul 10% Owner | 0 | $0 | 1,469,482 (Indirect) | View |
| 2023-01-20 Option Award | 2023-02-02 8:15 pm | N/A 2033-01-20 | Aceragen Inc. | ACGN | Kirby John J. CHIEF FINANCIAL OFFICER | 25,400 | $0 | 25,400 (Direct) | View |
| 2023-01-20 Option Award | 2023-02-02 8:13 pm | N/A 2033-01-20 | Aceragen Inc. | ACGN | JORDAN ANDREW R CHIEF STRATEGY OFFICER | 25,400 | $0 | 25,400 (Direct) | View |
| 2023-01-20 Option Award | 2023-02-02 8:12 pm | N/A 2033-01-20 | Aceragen Inc. | ACGN | Salain Daniel CHIEF OPERATING OFFICER | 25,400 | $0 | 25,400 (Direct) | View |
| 2023-01-20 Option Award | 2023-02-02 8:10 pm | N/A 2033-01-20 | Aceragen Inc. | ACGN | Kraus Carl N CHIEF MEDICAL OFFICER | 25,400 | $0 | 25,400 (Direct) | View |
| 2023-01-20 Option Award | 2023-02-02 8:08 pm | N/A 2033-01-20 | Aceragen Inc. | ACGN | Lim Bryant David SVP AND GENERAL COUNSEL | 25,400 | $0 | 25,400 (Direct) | View |
| 2023-01-20 Option Award | 2023-02-02 8:06 pm | N/A 2033-01-20 | Aceragen Inc. | ACGN | Taylor John Clayton CHIEF EXECUTIVE OFFICER | 74,500 | $0 | 74,500 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 9:47 pm | N/A N/A | Aceragen Inc. | ACGN | JORDAN ANDREW R Chief Strategy Officer | 409,372 | $0 | 451,890 (Direct) | View |
| 2023-01-17 Conversion | 2023-01-19 9:47 pm | 2022-09-28 2031-03-23 | Aceragen Inc. | ACGN | WOOTEN RONALD J Director | 844,409 | $0 | 830,294 (Indirect) | View |
| 2023-01-17 Exercise | 2023-01-19 9:46 pm | N/A N/A | Aceragen Inc. | ACGN | Salain Daniel Chief Operating Officer | 1,364,574 | $0 | 1,469,482 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 9:46 pm | N/A 2032-02-09 | Aceragen Inc. | ACGN | Kraus Carl N Chief Medical Officer | 440,844 | $0 | 440,844 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 9:45 pm | N/A N/A | Aceragen Inc. | ACGN | Taylor John Clayton Chief Executive Officer | 1,364,574 | $0 | 1,469,482 (Direct) | View |
| 2023-01-17 Conversion | 2023-01-18 4:46 pm | 2022-09-28 2031-03-23 | Aceragen Inc. | ACGN | NovaQuest Co-Investment Fund XV L.P. NQ POF V GP Ltd. See Remarks | 844,409 | $0 | 830,294 (Direct) | View |
| 2023-01-11 Option Award | 2023-01-12 8:00 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | DOUGHERTY MICHAEL R Director | 33,523 | $0.44 | 375,155 (Direct) | View |
| 2023-01-06 Tax Withholding | 2023-01-10 9:19 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | JORDAN ANDREW R CHIEF STRATEGY OFFICER | 73,940 | $0.7099 | 839,142 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-10 9:19 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | JORDAN ANDREW R CHIEF STRATEGY OFFICER | 261,718 | $0 | 839,142 (Direct) | View |
| 2023-01-06 Tax Withholding | 2023-01-10 9:17 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP AND GENERAL COUNSEL | 119,957 | $0.7099 | 309,695 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-10 9:17 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP AND GENERAL COUNSEL | 399,218 | $0 | 309,695 (Direct) | View |
| 2023-01-06 Tax Withholding | 2023-01-10 9:15 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | Kirby John J. CHIEF FINANCIAL OFFICER | 119,957 | $0.7099 | 316,893 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-10 9:15 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | Kirby John J. CHIEF FINANCIAL OFFICER | 399,218 | $0 | 316,893 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 9:26 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | DOUGHERTY MICHAEL R Director | 58,516 | $0.3749 | 341,632 (Direct) | View |
| 2022-09-28 Other | 2022-10-03 6:06 pm | 2022-09-28 2031-03-23 | IDERA PHARMACEUTICALS INC. | IDRA | NovaQuest Co-Investment Fund XV L.P. NQ POF V GP Ltd. See Remarks | 1,371,782 | $0 | 1,371,787 (Direct) | View |
| 2022-09-28 Other | 2022-09-30 9:50 pm | 2022-09-28 2031-03-23 | IDERA PHARMACEUTICALS INC. | IDRA | WOOTEN RONALD J Director | 1,371,782 | $0 | 1,371,787 (Indirect) | View |
| 2022-09-28 Option Award | 2022-09-30 9:49 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | Taylor John Clayton Chief Executive Officer | 2,194,024 | $0 | 2,194,024 (Direct) | View |
| 2022-09-28 Option Award | 2022-09-30 9:49 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | Salain Daniel Chief Operating Officer | 2,194,024 | $0 | 2,194,024 (Direct) | View |
| 2022-09-28 Option Award | 2022-09-30 9:48 pm | N/A 2032-02-09 | IDERA PHARMACEUTICALS INC. | IDRA | Kraus Carl N Chief Medical Officer | 665,050 | $0 | 665,050 (Direct) | View |
| 2022-09-28 Option Award | 2022-09-30 9:48 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | JORDAN ANDREW R Chief Strategy Officer | 658,207 | $0 | 658,207 (Direct) | View |
| 2022-09-22 Exercise | 2022-09-26 4:32 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | Pillar Invest Corp Pillar Partners Foundation L.P. Pillar Pharmaceuticals 6 L.P. Umari Abude ZEIN YOUSSEF EL 10% Owner | 1,533,159 | $0.01 | 11,516,711 (Indirect) | View |
| 2022-09-22 Exercise | 2022-09-26 4:32 pm | 2020-12-11 N/A | IDERA PHARMACEUTICALS INC. | IDRA | Pillar Invest Corp Pillar Partners Foundation L.P. Pillar Pharmaceuticals 6 L.P. Umari Abude ZEIN YOUSSEF EL 10% Owner | 1,533,159 | $0 | 11,516,711 (Indirect) | View |
| 2022-07-06 Option Award | 2022-07-07 5:33 pm | N/A 2032-07-06 | IDERA PHARMACEUTICALS INC. | IDRA | Lim Bryant David SVP AND GENERAL COUNSEL | 66,500 | $0 | 66,500 (Direct) | View |
| 2022-07-06 Option Award | 2022-07-07 5:30 pm | N/A 2032-07-06 | IDERA PHARMACEUTICALS INC. | IDRA | SOLAND DANIEL B CHIEF OPERATING OFFICER | 66,500 | $0 | 66,500 (Direct) | View |
| 2022-07-06 Option Award | 2022-07-07 5:29 pm | N/A 2032-07-06 | IDERA PHARMACEUTICALS INC. | IDRA | MILANO VINCENT PRESIDENT AND CEO | 124,000 | $0 | 124,000 (Direct) | View |
| 2022-07-06 Option Award | 2022-07-07 5:27 pm | N/A 2032-07-06 | IDERA PHARMACEUTICALS INC. | IDRA | Kirby John J. CHIEF FINANCIAL OFFICER | 66,500 | $0 | 66,500 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:30 pm | N/A N/A | IDERA PHARMACEUTICALS INC. | IDRA | DOUGHERTY MICHAEL R Director | 50,086 | $0.438 | 283,116 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:31 pm | 2023-06-23 2032-06-23 | IDERA PHARMACEUTICALS INC. | IDRA | GOWEN MAXINE Director | 26,000 | $0 | 26,000 (Direct) | View |